Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €144.20 | €228.30 | 58.322% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €131.00 | €140.34 | 7.130% |
| Jazz Pharmaceuticals plc | 21 | 0 | 2 | 0 | €101.65 | €184.14 | 81.151% |
| Icon plc | 18 | 0 | 6 | 0 | €280.90 | €318.99 | 13.562% |
| United Therapeutics | 18 | 0 | 3 | 0 | €240.70 | €288.66 | 19.926% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €70.50 | €86.90 | 23.258% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.00 | €82.93 | 107.328% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €164.95 | €215.54 | 30.668% |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €84.00 | €92.26 | 9.833% |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | €37.15 | €53.50 | 43.998% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Alkermes plc | 12 | 2 | 1 | 0 | €22.00 | €34.08 | 54.912% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.80 | 5.282% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €63.00 | €109.59 | 73.944% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| PTC Therapeutics Inc. | 14 | 5 | 3 | 0 | €31.00 | €41.51 | 33.911% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €368.80 | €421.61 | 14.318% |
| LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €109.00 | €116.50 | 6.877% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.65 | €65.00 | -2.476% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €102.60 | €110.00 | 7.212% |